• Explore /
  • Poster
  • / Genomic mutations and homologous recombination deficiency (HRD) score in Japanese patients with metastatic hormone-sensitive prostate cancer (mHSPC): The impact of intraductal carcinoma of the prostate (IDC-P).

Genomic mutations and homologous recombination deficiency (HRD) score in Japanese patients with metastatic hormone-sensitive prostate cancer (mHSPC): The impact of intraductal carcinoma of the prostate (IDC-P).

Abstract Poster

Authors

null

Masashi Kato

Nagoya University Graduate School of Medicine, Nagoya, Japan

Masashi Kato , Akiyuki Yamamoto , Hideji Kawanishi , Yushi Naito , Shusuke Akamatsu , Toyonori Tsuzuki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 195)

DOI

10.1200/JCO.2024.42.4_suppl.195

Abstract #

195

Poster Bd #

J3

Abstract Disclosures

Similar Posters

First Author: Santosh Gupta

First Author: Justine Panian

First Author: Colin P. Bergstrom

Poster

2023 ASCO Annual Meeting

Clinical implications of molecular alterations in intraductal carcinoma of the prostate.

Clinical implications of molecular alterations in intraductal carcinoma of the prostate.

First Author: Benjamin Miron